ViGenCell Inc (308080)

Currency in KRW
5,680
-60(-1.05%)
Closed·
Advertisement
308080 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5,3505,930
52 wk Range
2,91017,360
Key Statistics
Bid/Ask
5,680.00 / 5,690.00
Prev. Close
5,740
Open
5,710
Day's Range
5,350-5,930
52 wk Range
2,910-17,360
Volume
231K
Average Volume (3m)
1.08M
1-Year Change
89.3333%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
308080 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15/05/2025
EPS / Forecast
-132.00 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Compare 308080 to Peers and Sector

Metrics to compare
308080
Peers
Sector
Relationship
P/E Ratio
0.0x−5.2x−0.4x
PEG Ratio
0.00−0.190.00
Price/Book
0.0x1.8x2.6x
Price / LTM Sales
0.0x7.1x3.1x
Upside (Analyst Target)
0.0%110.5%48.8%
Fair Value Upside
Unlock29.5%6.3%Unlock

ViGenCell Inc. provides immune cell therapy in South Korea. It develops ViTier, an antigen-specific killer T cell therapy, such as VT-EBV-N for NK/T Lymphoma indications and VT-Tri(1)-A for AML indications; ViMedier, a cord blood-derived myeloid suppressor cell therapy, including VM-GD for GvHD indications and VM-AD for atopic dermatitis indications; and ViRanger, an off-the-shelf allogenic universal T cell gene therapy comprising VR-CAR and VR-GDT for hepatoma and leukemia indications. The company was founded in 2013 and is based in Seoul, South Korea.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
4.83M23.59%27.45B
Public Companies & Retail Investors
15.65M76.41%88.89B
Total
20.48M100.00%116.35B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gaeun Global Co.,Ltd10.68%2,190,00012,439,200
Boryung Corporation5.00%1,024,9635,821,790

People Also Watch

119,300
001820
-2.37%
2,605
357880
-3.52%
12,240
010170
+2.34%
74,200
064400
-5.24%
192,600
036930
-15.34%

FAQ

What Is the ViGenCell (KOSDAQ: 308080) Share Price Today?

The ViGenCell stock price today is 5,680 KRW.

What Stock Exchange Does ViGenCell (308080) Trade On?

ViGenCell is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for ViGenCell?

The stock symbol (also called a 'ticker') for ViGenCell is "308080."

What Is the Current ViGenCell Market Capitalisation?

As of today, ViGenCell (KOSDAQ: 308080) market cap is 116.44B KRW.

What Is ViGenCell's (308080) Earnings Per Share (TTM)?

The ViGenCell EPS is currently -651 (Trailing Twelve Months).

Is 308080 a Buy or Sell From a Technical Analyst Perspective?

Based on today's ViGenCell moving averages and other technical indicators, the daily buy/sell signal for 308080 stock is Strong Sell.

How Many Times Has ViGenCell Stock Split?

ViGenCell has split 1 times. (See the 308080 stock split history page for full effective split date and price information.)

How Many Employees Does ViGenCell Have?

ViGenCell has 64 employees, based on their latest Companies House report.

What is the current trading status of ViGenCell (KOSDAQ: 308080)?

As of 05/07/2026, ViGenCell (308080) is trading at a share price of 5,680 KRW, with a previous close of 5,740 KRW. The stock has fluctuated within a day range of 5,350 KRW to 5,930 KRW, while its 52-week range spans from 2,910 KRW to 17,360 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.